iSpecimen Inc. (ISPC): Revenue
$1.93M
Year ended 2025-12-31
$466.3K
Trailing 12 months to 2026-06-30
-43.0%
3-year compound annual growth
-25.1%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.93M | -79.2% | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | $9.29M | -6.4% | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | $9.93M | -4.6% | 2025-04-14, From 2023-01-01 |
| 2022-12-31 | $10.40M | -6.6% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $11.14M | +36.1% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $8.18M | n/a | 2022-03-22, From 2020-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | 2025-12-31 | $1.93M | -79.2% |
| OneMedNet Corp (ONMD) | 2025-12-31 | $1.36M | +111.4% |
| Absci Corp (ABSI) | 2025-12-31 | $2.80M | -38.2% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $6.16M | -34.2% |
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | $303.0K | +21.8% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $16.37M | +304.0% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $18.67M | -29.3% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $33.03M | -14.5% |
| NRC Health (NRC) | 2025-12-31 | $137.39M | -4.0% |
Compare ISPC, ONMD, ABSI, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗